Ask The Board

1. How Would “Medicare For All” Be Financed?
   1/2/2019

   See the answer from Ron Cohen, M.D., president, CEO, and founder of Acorda Therapeutics.

2. How Have Current Tensions Between Mexico And The White House Impacted Biopharma Manufacturing Operations Located In Mexico?
   1/2/2019

   See the answer from Raul Diaz who directs MSD Animal Health Large Molecules Biopharm Operations in Montes Claros, Brazil. He has managed Merck manufacturing facilities in Europe, Mexico, and the United States.

3. How Do Leaders Transition From A Functional Role To A GM-Like Role?
   1/2/2019

   See the answer from Sandy Macrae, M.B., Ch.B., Ph.D., CEO of Sangamo Therapeutics. He has over 20 years of leadership experience in the pharmaceutical industry.

4. What Industry Trend Are You Paying Closest Attention To?
   12/3/2018

   See the answer from Fred Hassan, the managing director at Warburg Pincus and former chairman of Bausch & Lomb.

5. What Supply Chain Trends Are You Paying Closest Attention To?
   12/3/2018

   See the answer from Anu Hans, VP of strategic initiatives at Janssen Supply Chain.

6. What Geopolitical Issue Are You Paying Closest Attention To?
   12/3/2018

   See the answer from Carol Nacy, CEO of Sequella, Inc., a private company that develops new anti-infective drugs.

7. To What Extent Do You Believe That The Combination Of Quality/Relevance Of Products (Or Service), Corporate Culture, And Corporate Values Drives The Successful Integration Of A Company Following A Merger?
   11/7/2018

   See the answer from Thomas Wiggans, chairman and CEO of Dermira.

8. What Advice Do You Have For Companies On Building The Science Of Patient Input Into Clinical Trial Development And Execution?
   11/7/2018

   See the answer from Margaret Anderson, a managing director at Deloitte and previous executive director at FasterCures.

9. Are The Economics Of Healthcare Delivery Consistent With Classic Theories Of Supply And Demand? It Seems Not When Consumers Are Not The Payers.
   11/7/2018

   See the answer from Jeff Berkowitz, CEO and director of Real Endpoints, a data/analytics advisory firm.

10. What Are The Current Trends For Where Compliance Reports In Small To Midsize Life Sciences Companies?
    10/4/2018

    See the answer from Jason Urban, Ph.D., the head of Celgene’s Business Operational Excellence function.